Strongbridge Biopharma plc Launches the Uncovering Periodic Paralysis Genetic Testing Program
DUBLIN, Ireland and TREVOSE, Pa., Sept. 25, 2017 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with …